Singapore’s Thrixen raises $7M in funding round co-led by 22Health Ventures and John Ballantyne

Thrixen, a Singapore-based medical technology start-up, has on Monday announced the successful close of an oversubscribed funding round, raising $7 million capital to accelerate the development of its innovative diagnostic technology platform for multiplex point of care testing.